Articles by Alejandro Portillo - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Alejandro Portillo

Alejandro Portillo


Quality Control Specialist at the Centro de Inmunología Molecular (Center for Molecular Immunology)

Manufacturing Process Development for an Epidermal Growth Factor-Based Cancer Vaccine
October 2, 2008

The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.

ADVERTISEMENT

ADVERTISEMENT

Click here